<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a rare immune-mediated complication of <z:hpo ids='HP_0100522'>thymoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100522'>Thymomas</z:hpo>, especially of the cortical type, have the capacity to generate mature T-cells from their immature precursors </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, mature intratumorous T-cells have an increased autoantigen-specific potential </plain></SENT>
<SENT sid="3" pm="."><plain>We present the case of a 75-year-old patient with an inoperable cortical <z:hpo ids='HP_0100522'>thymoma</z:hpo> who developed <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> 7 years after the initial diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>The infiltration of the bone marrow by these cells was accompanied by the production of cytokines such as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha) in the microenvironment of bone marrow and in the serum sample </plain></SENT>
<SENT sid="5" pm="."><plain>The patient was successfully treated with oral <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A for 14 months and when she died due to progression of the <z:hpo ids='HP_0100522'>thymoma</z:hpo>, 9 months after the discontinuation of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>, the <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> had not recurred </plain></SENT>
</text></document>